SINGH SHAWN (CHIEF EXECUTIVE OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/1/2020ACC: 0001415889-20-001764
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
+5K
Net shares
Net buyer
$2.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$0.45
Trade value
$2.24K
% of position
19.7%
6/30/2020
25.38K→30.38K
Total
Net shares
+5K
Net value
$2.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2020 | A · Award | +5K | $0.45 | $2.24K | 19.7% | 25.38K | 30.38K |
| Total | +5K | $2.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned26.23K
Total
26.23K indirect26.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.23K | Indirect |
| Total | 26.23K | 26.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported